Next 10 |
home / stock / abt / abt articles
U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Wednesday. Following the market opening Wednesday, th...
Wednesday, Abbott Laboratories (NYSE:ABT) reported first-quarter sales of $9.96 billion, up 10.8% on an organic basis for the underlying ...
U.S. stocks are priming for a firmer start on Wednesday, potentially striving to inflect higher from the weakness seen so far in April. As some bul...
With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street...
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes New Fortress Energy Inc. (NYSE: NFE), but "right now Wes Ede...
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Abbott Laboratories (NYSE: ABT) over Penumbra, Inc. (NYSE: PE...
Tuesday, the FDA approved Abbott Laboratories’ (NYSE:ABT) first-of-its-kind TriClip transcatheter edge-to-edge repair (TEER) system...
In the ever-changing and fiercely competitive business landscape, conducting thorough company analysis is crucial for investors and industry expert...
An Illinois jury has issued a verdict compelling Reckitt Benckiser Group Plc’s (OTC:RBGLY) (OTC:RBGPF) Mead Johnson to pa...
News, Short Squeeze, Breakout and More Instantly...
Abbott Laboratories Company Name:
ABT Stock Symbol:
NYSE Market:
NORTHAMPTON, MA / ACCESSWIRE / April 23, 2024 / Abbott Eleven new HeartMates with 11 inspiring stories recognized at Abbott HeartMates Draft Day event in NYC. Abbott Just a week before the pro football draft, Abbott held a high-profile draft day experience for our HeartMates program. Hos...
2024-04-18 23:00:03 ET Lee Hambright from Bernstein issued a price target of $133.00 for ABT on 2024-04-18 21:44:00. The adjusted price target was set to $133.00. At the time of the announcement, ABT was trading at $105.27. The overall price target consensus is at $129.8...
2024-04-18 08:15:07 ET RBC Capital analyst issues OUTPERFORM recommendation for ABT on April 18, 2024 06:19AM ET. The previous analyst recommendation was Outperform. ABT was trading at $105.9 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...